Adverum Biotechnologies, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.67
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.34
|
-0.40
|
-0.06
|
-17.65%
|
|
2022-06-30
|
-0.34
|
-0.44
|
-0.10
|
-29.41%
|
|
2022-03-31
|
-0.31
|
-0.38
|
-0.07
|
-22.58%
|
|
2021-12-31
|
-0.34
|
-0.35
|
-0.01
|
-2.94%
|
|
2021-09-30
|
-0.37
|
-0.39
|
-0.02
|
-5.41%
|
|
2021-06-30
|
-0.39
|
-0.45
|
-0.06
|
-15.38%
|
|
2021-03-31
|
-0.38
|
-0.29
|
0.09
|
23.68%
|
|
2020-12-31
|
-0.32
|
-0.39
|
-0.07
|
-21.88%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.22
|
|
2021-12-31
|
-1.48
|
|
2020-12-31
|
-1.37
|
|
2019-12-31
|
-1.00
|
|
2018-12-31
|
-1.19
|
|
2017-12-31
|
-1.29
|
|
2016-12-31
|
-3.22
|
|
2015-12-31
|
-1.76
|
|
2014-12-31
|
-3.23
|